Hi All,
I know some shareholders are probably frustrated and concerned with the MC and the overall negative sentiment atm.
I, like many have been a patient shareholder for a long while.
The way I see it atm is that our board have outlined the next steps in concrete (below) and they will need to deliver on their public announcements regardless of any excuses.
It is now over 2 months since the PFS was released and just over 2 months till we enter the holiday zone of Dec/Jan.
The below statements in bold will need to be achieved by the board before that time and I believe that they know this only too well.
I'm sure that they will be reminded of this weekly by shareholders.
Clear Strategy for Development
•Completion of ESIA process; report submission and
environmental permitting
•Completion of Exploitation (Mining) Licence
approval process
•Completion of FS and definitive engineering studies
•Signing of binding offtake agreements
•Securing of Project financing
•Procurement and ordering of long lead
time items
•Construction, commissioning and production ramp
up.
•Commencement of Production by H1 2020
Key Investment Takeaways
•Goulamina benefits from robust project
economics
•The deposit is large scale and low cost
•Birimian is on track to deliver its development
strategy
•Production profile of 362,000 tpa 6% Li2O
Concentrate (50,000 tpa LCE) by H1 20
From CEO Greg Walker on the PFS released 4 July 2018
“I am particularly pleased that the objectives we set for this PFS process have been successfully achieved.
Our ability to satisfy the long-term requirements of strategic offtake partners is now clearly demonstrated.” he said.
- Forums
- ASX - By Stock
- FFX
- Current SP and any other thoughts
Current SP and any other thoughts, page-537
-
- There are more pages in this discussion • 7,192 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online